Increasing Availability Of Advanced Clotting Facto..

새 기사를 만들었습니다

10 안에

Increasing Availability Of Advanced Clotting Factor Therapies Is Driving Growth In The Hemophilia B Market | #hemophilia B

Increasing Availability Of Advanced Clotting Factor Therapies Is Driving Growth In The Hemophilia B Market

Increasing Availability Of Advanced Clotting Factor Therapies Is Driving Growth In The Hemophilia B Market

Hemophilia B is a rare inherited bleeding disorder caused by a deficiency or dysfunction of clotting factor IX, leading to prolonged bleeding episodes, spontaneous hemorrhages, and joint damage.

처럼

논평

공유하다